首页> 美国卫生研究院文献>The Scientific World Journal >Synthesis and Anti–Mycobacterium tuberculosis Evaluation of Aza-Stilbene Derivatives
【2h】

Synthesis and Anti–Mycobacterium tuberculosis Evaluation of Aza-Stilbene Derivatives

机译:氮杂-二苯乙烯衍生物的合成及结核分枝杆菌的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tuberculosis (TB) is a truly global disease, found in every country on earth. One-third of humanity, over 2 billion people, carry the bacillus that causes TB and 2 million people die of the disease each year. Despite that, no new specific drug against Mycobacterium tuberculosis has been developed since the 1960s. There are several candidates for new anti-TB agents, but none proven clinically effective. Stilbenes are compounds found in numerous medicinal plants and food products with some known biological and even antimycobacterial activity. This paper describes the synthesis and the anti–M. tuberculosis activity of eight stilbene analogues. The synthesis and characterization of these compounds are shown, and the results compared with one “first”-line drug used in current therapy.
机译:结核病(TB)是一种真正的全球性疾病,在地球上的每个国家都有发现。超过20亿的人类人口中,三分之一携带导致结核病的杆菌,每年有200万人死于该病。尽管如此,自1960年代以来,尚未开发出针对结核分枝杆菌的新的特异性药物。有几种抗结核新药的候选药物,但没有一种被证明具有临床疗效。对苯二酚是在许多药用植物和食品中发现的化合物,具有某些已知的生物学甚至抗分枝杆菌活性。本文描述了合成和抗-M。八苯乙烯类似物的结核病活性。显示了这些化合物的合成和表征,并将结果与​​当前疗法中使用的一种“一线”药物进行了比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号